Abstract:Previously transplanted highly sensitized patients experience problems with subsequent transplantation. It is also difficult to provide optimal hemodynamic conditions during successive kidney transplantation in heart transplant recipients. Patient and methods: We present a case of a 56-year old patient with end-stage renal failure after heart transplantation performed 21 years ago and hemodialyzed using arteriovenous fistula. The patient had 69% panel-reactive antibodies, had been on the active waiting list since 2013, and presented 335 positive crossmatches with deceased donors. He also positively crossmatched with a potential living donor. Detailed examination of anti-HLA antibodies revealed the absence of IgG donor-specific antibodies and negative crossmatch with dithiothreitol-treated serum. The transplantation from his wife was performed with positive crossmatch after 4 plasma exchanges and thymoglobulin induction. Because sympathetic and parasympathetic denervation of the transplanted heart and the presence of arteriovenous fistula induced volume overload of the right heart, we used central venous pressure (CVP) and the PiCCO2 for postsurgical assessment of cardiac output. Results: Monitoring, like CVP and other static exponents of preload obtained by PICCO (extravascular lung water, global end-diastolic volume index) as well as the dynamic parameters obtained by PiCCO2 (pulse pressure variation, stroke volume variation), was not sensitive enough to describe recipient volume status. The immediate graft function was observed, and after 11 months satisfactory estimated glomerular filtration rate is noted with the absence of donor-specific antibodies. Conclusion: The history of heart transplantation with existing arteriovenous fistula makes clinical tools such as continuous cardiac output monitoring and CVP parameter inadequate for describing the hemodynamic situation. The high level of panel-reactive antibodies and positive crossmatch possibly caused by IgM antibodies do not have to withdraw the recipient from kidney transplantation.

Combined Heart and Kidney Transplantation from the Same Donor As Treatment for End-Stage Heart and Renal Failure (report of One Case)

Simultaneous pancreas-kidney transplantation: a report of 5 cases

Extended criteria donor reconditioning and functional improvement in the viewshed of machine perfusion plus

Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy

An Experimental Study on Immune Protective Role of Combined Transplantation of Liver and Kidney

Two Cases of Combined Liver-Kidney Transplantation.

Outcome of Single Kidney Transplant from Pediatric Donors Younger Than 5 Years of Age after Cardiac Death in China: A Single Center Experience

Combined Heart and Kidney Transplantation: Initial Clinical Experience

Simultaneous Hepatorenal Transplantation: Two Cases Report

Simultaneous Heart and Kidney Transplantation: A Systematic Review and Proportional Meta-Analysis of Its Characteristics and Long-Term Variables

Consensus conference on heart‐kidney transplantation

Combined Kidney and Pancreaticoduodenal Transplantation in One Diabetics Patient with End-Stage Kidney Disease

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

Kidney Transplantation from Small Pediatric Donors May Be Feasible to Those Who Developed Chronic Refractory Dialysis Hypotension: a Single-Center Experience.

Orthotopic Heart Transplantations for End-Stage Heart Diseases

Renal Transplantation Combined with Hematopoietic Stem Cell Transplantation As Induction Therapy: Seven Cases Report

[Orthotopic Heart Transplantation: Clinical Experience on 56 Patients].

Experience of Combined Heart-lung Transplantation for 2 Eisenmenger′s Syndrome Patients

Orthotopic Heart Transplantation for 5 Cases of End-Staged Coronary Heart Disease

Clinical Application in Single-Lung Transplantation from the Same Donor for Later-Stage Lung Diseases

The Impact on the Donors and the Recipients of the Live Donor Renal Transplantation